Rafarma pharmaceutical updates
December 18, 2024 09:00 ET
|
Rafarma Pharmaceuticals Inc.
Sheridan, Wyoming, USA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) Dear Rafarma shareholders, We apologize for the delay in providing information about the company's...
Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea
July 04, 2024 09:30 ET
|
Rafarma Pharmaceuticals Inc.
Sheridan, Wyoming, USA, July 04, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - Rafarma Pharmaceuticals is pleased to announce its participation in the scientific conference on...
Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care
July 03, 2024 09:30 ET
|
Rafarma Pharmaceuticals Inc.
Sheridan, Wyoming, USA, July 03, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - Rafarma Pharmaceuticals is pleased to announce the signing of a preliminary agreement to establish a...
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
December 11, 2023 09:30 ET
|
Rafarma Pharmaceuticals Inc.
Sheridan, Wyoming, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement...
Rafarma Pharmaceutical news update
November 30, 2023 09:30 ET
|
Rafarma Pharmaceuticals Inc.
Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet...
Rafarma Pharmaceuticals strengthens its position in Central Asia
April 29, 2022 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, April 29, 2022 (GLOBE NEWSWIRE) -- Representatives of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) visited Uzbekistan and discussed the prospects for the company's development in the...
Rafarma’s Slavich Noya Technology Division Expands Printing Production
February 07, 2022 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) Slavich Noya Technology, part of the Rafarma Pharmaceuticals group of companies, is expanding its...
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research
December 21, 2021 10:50 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international...
RAFA To Add Major Component to the Tashkent Pharma Park
December 17, 2021 11:34 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and the Czech company “Block” signed an agreement on the implementation of the construction of a...
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5
November 19, 2021 09:25 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that PJSC Kraspharma at the end of 2020 entered the TOP-5 of the most dynamic and largest...